Meabh O’Hare

Fellow of Neurology Brigham and Women's Hospital

Meabh J. O’Hare, MBBCh, is a board-certified neurologist specializing in neuromuscular disease and electrodiagnostic medicine. She completed her medical degree at University College Dublin, followed by clinical training at Mater Misericordiae Hospital and California Pacific Medical Center. Dr. O’Hare undertook her neurology residency and fellowship at Brigham and Women’s Hospital, where she developed expertise in neuromuscular disorders. Board-certified in Neurology and Electrodiagnostic Medicine, she is dedicated to advancing patient care through clinical excellence and research. Dr. O’Hare is recognized for her commitment to diagnosing and managing complex neuromuscular conditions and improving patient outcomes.

Seminars

Thursday 27th August 2026
Leveraging Clinical Phenotyping to Optimize ADC Dosing & Mitigate Neurologic Toxicities for Improved Patient Safety
9:00 am
  • Applying detailed clinical phenotyping and electrophysiologic assessment to distinguish between immune-mediated and direct payload-related neurologic toxicities, enabling more precise dose modification and management strategies
  • Characterizing neuromuscular toxicity patterns across ADC-treated patients to identify early clinical signals and correlate toxicity phenotypes with dosing exposure, supporting safer therapeutic windows
  • Developing a clinician-led framework to differentiate subtypes of peripheral neuropathy and neuromuscular junction disorders, informing mechanism-driven management approaches and guiding multidisciplinary decision-making for treatment continuation or discontinuation
Meabh O'Hare Brigham And Womens Hospital- speaker for 4th ADC Toxicity Summit